LOVELAND, CO – January 27, 2026 – PRESSADVANTAGE –
As awareness grows around early detection and management of glaucoma, individuals in the region have local access to a full spectrum of advanced treatment options through Vance Thompson Vision. Patients seeking care for glaucoma in Northern Colorado can rely on a team with deep expertise in diagnosing, managing, and researching this complex eye disease.
Glaucoma remains one of the most common causes of irreversible blindness worldwide. Often called the “silent thief of sight,” the condition progresses slowly and without symptoms in its early stages. Damage occurs when elevated intraocular pressure harms the optic nerve, and once vision is lost, it cannot be restored. Timely diagnosis and effective treatment are essential to protecting long-term visual function.
The clinical team in Northern Colorado provides personalized care plans based on each patient’s unique diagnosis. Evaluation begins with comprehensive diagnostic imaging, pressure testing, and visual field assessments. Depending on findings, doctors may recommend non-surgical therapies such as medicated eye drops to lower intraocular pressure or laser procedures that improve fluid drainage inside the eye.
For cases where medications and lasers are not sufficient, several surgical options are available. One commonly used method is Minimally Invasive Glaucoma Surgery (MIGS), which is designed to create new outflow pathways with minimal trauma to the eye. MIGS procedures are typically faster and less invasive than traditional surgeries, making them a good fit for patients with mild to moderate disease.
In more advanced cases, surgeons may consider traditional interventions such as trabeculectomy or the placement of drainage implants. These techniques are used when other treatments have not sufficiently controlled intraocular pressure or when the disease is progressing more aggressively. The choice of procedure is guided by patient-specific risk factors, anatomy, and clinical response to prior therapies.
Patients with both cataracts and glaucoma may be eligible for a combined approach. MIGS devices can often be implanted during cataract surgery, taking advantage of the same incision to address two conditions simultaneously. This combination can reduce surgical recovery time and improve overall efficiency of care.
The doctors at Vance Thompson Vision are deeply involved in clinical research aimed at improving outcomes for individuals with glaucoma. As part of a wider research network, the Northern Colorado team contributes to studies that evaluate new technologies and surgical techniques, helping to advance national standards for glaucoma care. Their work is informed by the latest data on disease progression, treatment durability, and long-term safety.
The first step for most patients is a detailed consultation where the type of glaucoma is identified—whether open-angle, angle-closure, or a secondary form—and a treatment path is created. Procedures may take anywhere from 15 minutes to two hours depending on complexity. Recovery times also vary, but most patients can expect some temporary eye irritation and mild blurriness immediately following surgery. These symptoms generally improve in the days and weeks that follow.
Although a glaucoma diagnosis can be concerning, the outlook is optimistic for those who receive consistent monitoring and appropriate treatment. Many patients are able to maintain an active lifestyle with little to no impact on their daily routine. Routine follow-ups allow the medical team to track intraocular pressure, assess optic nerve health, and make any needed adjustments to therapy.
Genetics and age remain key risk factors for glaucoma. Individuals with a family history of the condition, those over age 60, or those with certain co-existing medical conditions should prioritize annual eye exams. These exams often include pressure checks and optic nerve imaging—tools that are critical for detecting glaucoma before symptoms arise.
The Northern Colorado location reflects Vance Thompson Vision’s commitment to making high-level glaucoma care available throughout the Midwest and Rocky Mountain regions. Each provider at this location brings specialized training and works collaboratively with optometrists and referring physicians to support continuity of care.
More information about the glaucoma services offered in Northern Colorado, as well as details about physician credentials, research initiatives, and available technologies, is available on the Vance Thompson Vision website. Patients seeking evaluation or ongoing management are encouraged to schedule an appointment to explore their options.
Vance Thompson Vision continues to be recognized for its leadership in subspecialty eye care, with glaucoma representing one of its foundational service areas. The Northern Colorado team carries forward that legacy through evidence-based practices, surgical precision, and a shared goal of preventing avoidable vision loss in the local community.
###
For more information about Vance Thompson Vision – Northern Colorado, contact the company here:
Vance Thompson Vision – Northern Colorado
Vance Thompson Vision
970-775-5453
info@vancethompsonvision.com
2975 Ginnala Dr STE 120, Loveland, CO 80538
